1.
AIDS
; 20(11): 1561-2, 2006 Jul 13.
Article
in English
| MEDLINE
| ID: mdl-16847415
2.
Lancet
; 362(9390): 1152-3, 2003 Oct 04.
Article
in English
| MEDLINE
| ID: mdl-14550705
Subject(s)
Acquired Immunodeficiency Syndrome/prevention & control , Attitude to Health , Financing, Organized/economics , HIV Infections/prevention & control , Health Care Costs , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/economics , AIDS-Related Opportunistic Infections/prevention & control , Acquired Immunodeficiency Syndrome/drug therapy , Acquired Immunodeficiency Syndrome/economics , Africa/epidemiology , Anti-HIV Agents/economics , Anti-HIV Agents/therapeutic use , Cost of Illness , Cost-Benefit Analysis , Drug Resistance, Viral , HIV Infections/drug therapy , HIV Infections/economics , Humans
3.
Washington, D.C; Banco Mundial; jun. 1992. 71 p.
Monography
in Spanish
| PAHO
| ID: pah-15486